
Johnson Pharmacare (JOHNPHARMA) | Stock Overview & Key Data
Johnson Pharmacare Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹7.14 on January 3, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Johnson Pharmacare JOHNPHARMA | 434.50M Small-cap | -1.27% | -9.30% | -14.29% | -21.21% | -30.97% | -40.91% | 1.30% | -83.98% |
Beml Land Assets BLAL | 8.67B Small-cap | 1.78% | -1.71% | 1.32% | 0.23% | -11.06% | -24.16% | -15.27% | -15.27% |
Cupid Breweries CUPIDALBV | 5.09B Small-cap | -5.64% | -8.24% | -0.71% | -34.92% | 44.17% | 229.80% | 229.80% | 229.80% |
Yash Trading YASTF | 1.70B Small-cap | -5.84% | -28.90% | -14.59% | 132.80% | 132.80% | 123.80% | 811.36% | 811.36% |
Vr Woodart VRWODAR | 762.61M Small-cap | 3.94% | 39.43% | 25.46% | 163.99% | 163.99% | 153.84% | 153.84% | 771.29% |
Transchem TRANSCHEM | 571.49M Small-cap | 24.23% | 14.97% | 15.95% | 11.38% | -1.13% | 27.10% | 139.22% | 217.25% |
Ownership & Short Interest
Johnson Pharmacare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Johnson Pharmacare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is JOHNPHARMA's 52-week high and low?
- In the last 52 weeks, Johnson Pharmacare reached a high of ₹1.44 (on August 27, 2024) and a low of ₹0.76 (on August 14, 2025).
- What is the market cap and P/E ratio for JOHNPHARMA?
- Curious about Johnson Pharmacare's size and valuation? Its market capitalization stands at 434.50M. When it comes to valuation, the P/E ratio (trailing twelve months) is -79.00, and the forward P/E (looking ahead) is N/A.
- Does JOHNPHARMA pay dividends? If so, what's the yield?
- As for dividends, Johnson Pharmacare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Johnson Pharmacare's main competitors or similar companies to consider before investing?
When looking at Johnson Pharmacare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Beml Land Assets
BLAL8.67B Financial Services Shell Companies -24.16% -15.27% Cupid Breweries
CUPIDALBV5.09B Financial Services Shell Companies 229.80% 229.80% Yash Trading
YASTF1.70B Financial Services Shell Companies 123.80% 811.36% Vr Woodart
VRWODAR762.61M Financial Services Shell Companies 153.84% 153.84% Transchem
TRANSCHEM571.49M Financial Services Shell Companies 27.10% 139.22% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Johnson Pharmacare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Johnson Pharmacare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.04%, the Debt to Equity ratio from the most recent quarter is 1.08, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for JOHNPHARMA?
- Looking at Johnson Pharmacare's growth, its revenue over the trailing twelve months (TTM) was INR-3M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of JOHNPHARMA stock is held by insiders and institutions?
- Wondering who owns Johnson Pharmacare stock? Company insiders (like executives and directors) hold about 5.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.